Plasma Ion Activated Expanded Polytetrafluoroethylene Vascular Grafts with a Covalently Immobilized Recombinant Human Tropoelastin Coating Reducing Neointimal Hyperplasia
- PMID: 33434982
- DOI: 10.1021/acsbiomaterials.6b00208
Plasma Ion Activated Expanded Polytetrafluoroethylene Vascular Grafts with a Covalently Immobilized Recombinant Human Tropoelastin Coating Reducing Neointimal Hyperplasia
Abstract
Expanded polytetrafluoroethylene (ePTFE) vascular conduits with less than or equal to 6 mm internal diameter typically occlude due to a combination of thrombus formation and neointimal hyperplasia. We hypothesized that by layering the polymerized elastin precursor, human tropoelastin, in the synthetic vessel lumen we could mimic the internal elastic lamina and so maintain low thrombogenicity while significantly reducing smooth muscle cell proliferation. The luminal surfaces of ePTFE conduits were activated with plasma immersion ion implantation (PIII) treatment to facilitate covalent attachment of tropoelastin. Multilayered tropoelastin vessels (2TE) enhanced endothelial cell attachment and proliferation in vitro and were superior to materials lacking the protein. In an ovine carotid interposition model of graft compatibility, partially tropoelastin coated vessels (1TE) thrombosed at a greater rate than control ePTFE, but 2TE maintained the same patency as controls. 2TE showed a significant reduction in neointimal area down to 9.7 ± 5.2% (p < 0.05) in contrast to 32.3 ± 3.9% for ePTFE alone. This reduction was due to a halving of the number of smooth muscle cells present and a corresponding reduction in their proliferation. 2TE, but not 1TE, enhanced the vascular compatibility of these materials: while both tropoelastin presentations increased in vitro endothelialization, only 2TE displayed the dual benefits of maintained hemocompatibility and simultaneously suppressed neointimal hyperplasia in vivo. We conclude that 2TE surface modification provides a significant improvement over ePTFE vascular conduits in a pilot large animal model study and presents an attractive path toward clinical applications for reduced diameter vessels.
Keywords: ePTFE; neointimal hyperplasia; tropoelastin; vascular graft.
Similar articles
-
Biomimetic Heparan Sulfate-Like Coated ePTFE Grafts Reduce In-graft Neointimal Hyperplasia in Ovine Carotids.Ann Vasc Surg. 2017 Apr;40:274-284. doi: 10.1016/j.avsg.2016.09.015. Epub 2017 Feb 3. Ann Vasc Surg. 2017. PMID: 28163179
-
Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.J Vasc Surg. 2005 Nov;42(5):980-8. doi: 10.1016/j.jvs.2005.06.018. J Vasc Surg. 2005. PMID: 16275457
-
In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model.J Vasc Surg. 2016 Jun;63(6):1620-1630.e4. doi: 10.1016/j.jvs.2015.01.060. Epub 2015 Mar 28. J Vasc Surg. 2016. PMID: 25827964 Free PMC article.
-
Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.J Vasc Surg. 2004 Jun;39(6):1322-8. doi: 10.1016/j.jvs.2004.01.046. J Vasc Surg. 2004. PMID: 15192575
-
In-vivo evaluation of silk fibroin small-diameter vascular grafts: state of art of preclinical studies and animal models.Front Surg. 2023 May 26;10:1090565. doi: 10.3389/fsurg.2023.1090565. eCollection 2023. Front Surg. 2023. PMID: 37304180 Free PMC article. Review.
Cited by
-
Improving Bioactive Characteristics of Small Diameter Polytetrafluoroethylene Stent Grafts by Electrospinning: A Comparative Hemocompatibility Study.Bioengineering (Basel). 2023 Mar 26;10(4):411. doi: 10.3390/bioengineering10040411. Bioengineering (Basel). 2023. PMID: 37106598 Free PMC article.
-
Coating small-diameter ePTFE vascular grafts with tunable poly(diol-co-citrate-co-ascorbate) elastomers to reduce neointimal hyperplasia.Biomater Sci. 2021 Aug 7;9(15):5160-5174. doi: 10.1039/d1bm00101a. Epub 2021 Apr 6. Biomater Sci. 2021. PMID: 34312627 Free PMC article.
-
A novel polymeric fibrous microstructured biodegradable small-caliber tubular scaffold for cardiovascular tissue engineering.J Mater Sci Mater Med. 2021 Mar 1;32(2):21. doi: 10.1007/s10856-021-06490-1. J Mater Sci Mater Med. 2021. PMID: 33649939 Free PMC article.
-
A cost-effective and enhanced mesenchymal stem cell expansion platform with internal plasma-activated biofunctional interfaces.Mater Today Bio. 2023 Jul 7;22:100727. doi: 10.1016/j.mtbio.2023.100727. eCollection 2023 Oct. Mater Today Bio. 2023. PMID: 37529421 Free PMC article.
-
Review of Polymeric Biomimetic Small-Diameter Vascular Grafts to Tackle Intimal Hyperplasia.ACS Omega. 2022 Jun 21;7(26):22125-22148. doi: 10.1021/acsomega.2c01740. eCollection 2022 Jul 5. ACS Omega. 2022. PMID: 35811906 Free PMC article. Review.